MAXIMUM PROTECTION
AGAINST UV AND BLUE LIGHT
Unique and certified Personal Protective Equipment that protects the cornea, crystalline lens, and retina against UV radiation, blue light, artificial light sources, and prolonged sun exposure, preventing damages like photo-keratitis, photo-keratoconjunctivitis, cataracts, and AMD.
DROP defence ® can be used with wearable contact lenses.
HOW IT WORKS
DROP defence ® is an anti UV ophthalmic protective solution, based on Vitamin B2 (riboflavin), Vitamin E TPGS, MSM, amino acids, and Hyaluronic Acid 0.1%. It acts as a shield for the ocular surface against UV and blue light, and improves ocular surface lubrication, contributing to corneal epithelium protection, against different stress sources. Sodium Hyaluronate mechanically interacts with the tear film mucin layer, retaining water and promoting longer stability of the ocular surface. The amino acids’ synergic action has a nourishing effect on the ocular surface (in addition to regulating pH and tears osmolarity), improving epithelial protection against stress caused by UV and blue light. Vitamin E TPGS promotes ocular surface wettability. The ophthalmic solution has a shielding, protective and antioxidant action against UV damage, and accelerates the natural repairing processes.
DROP defence ® is a unique and certified Personal Protective Equipment that protects, cornea, crystalline and retina against UV radiation, blue light, artificial light sources and prolonged sun exposure, preventing damages like photo-keratitis, photo-keratoconjunctivitis, cataract and AMD.
DROP defence ® keeps ocular surface hydrated and protected.
DROP defence ® can be used with wearable contact lenses.
DROP defence ® is a certified Personal Protective Equipment.
ACTION
Drop Defence ®:
has a protective action against UV, blue light, sunlight, and artificial light’s harmful effects.
prevents photo-keratitis and photo-keratoconjunctivitis occurrence, due to UV exposure.
prevents cataract occurrence, due to UV exposure.
prevents macular aging, caused by UV and blue light exposure.
is indicated in case of long exposure to computers, video terminals, and television.
is indicated in case of intense and prolonged UV rays exposure.
is indicated for outdoor sports and activities.
is indicated for exposures to high UV environments (mountain, sea, tropical areas, etc…).
its application does not affect visual acuity or chromatic perception and keeps contrast sensibility unchanged.
WHO IT IS FOR
DROP defence ® is indicated for the following applications:
PREVENTION
Damages caused by excessive UV and blue light exposure;
Children, teenagers, and frequent users of computers, video terminals, and television.
PROTECTION
During outdoor activities that can lead to excessive sun, UV, and blue light exposure
CURE
Ocular diseases that need higher protection against light.
SCIENTIFICALLY PROVEN
The combined protective effectiveness of DROP defence ® against UV and blue light was evaluated in an in vivo study, showing a highly protective effect against oxidative processes on aqueous humor and crystalline, secondary to UV exposure (with irradiation of 100 mW/cm2), while protecting the retina against photo-oxidative damage.
BIBLIOGRAPHY
- Vizzarri F, Palazzo M, Bartollino S, Casamassima D, Parolini B, Troiano P, Caruso C, Costagliola C. Effects of an antioxidant protective topical formulation on eye exposed to ultraviolet-irradiation: a study in rabbit animal model. Physiol Res. 2018 Mar 12.[PDF]
- Bartollino S., Palazzo M., Semeraro F., Parolini B., Caruso C., Merolla F., Guerra G., Costagliola C. Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits. Int Ophthalmol 2020.[PDF]
- Di Nezza F, Caruso C, Costagliola C, Ambrosone L Reaction-diffusion model as framework for understanding the role of riboflavin in “eye defence” formulations. RSC Adv., 2020, 10, 14965 [PDF].
- Palazzo M, Vizzarri F, Ondruška L, Rinaldi M, Pacente L, Guerra G, Merolla F,Caruso C, Costagliola C Corneal UV Protective Effects of a Topical Antioxidant Formulation: A Pilot Study on In Vivo Rabbits. Int. J. Mol. Sci. 2020, 21(15), 5426 [PDF]
